Back
Akari Therapeutics PLC Vs. Digimarc Industry Stock Comparison
Sell
48
AKTX
Akari Therapeutics PLC
Last Price:
$1.38
Seasonality Move:
-7.58%
Buy
69
DMRC
Digimarc
Last Price:
$47.29
Seasonality Move:
-0.46%
Sell
48
Akari Therapeutics PLC (AKTX)
is a Sell
Is Akari Therapeutics PLC a Buy, Sell or Hold?
-
The current Akari Therapeutics PLC [AKTX] share price is $1.41. The Score for AKTX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
AKTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AKTX Stock Price Chart
What is Akari Therapeutics PLC's stock price today?
-
The Akari Therapeutics PLC share price today is $1.41The current trend is relatively stagnant and AKTX is experiencing slight buying pressure.
DMRC Stock Price Chart
AKTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.05 | Sell |
Relative Strength Index (14 RSI): | 59.18 | Buy |
Chaikin Money Flow: | 12135 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.96 - 1.28) | Buy |
Bollinger Bands (100): | (1.4 - 3.3) | Sell |
DMRC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.95 | Buy |
Relative Strength Index (14 RSI): | 77.81 | Buy |
Chaikin Money Flow: | -50271 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
AKTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.18 | Buy |
20-day SMA: | 1.07 | Buy |
50-day SMA: | 1.57 | Sell |
200-day SMA: | 2.37 | Sell |
8-day EMA: | 1.24 | Buy |
20-day EMA: | 1.19 | Buy |
50-day EMA: | 1.54 | Sell |
200-day EMA: | 2.46 | Sell |
DMRC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 41.75 | Buy |
20-day SMA: | 38.6 | Buy |
50-day SMA: | 34.92 | Buy |
200-day SMA: | 29.48 | Buy |
8-day EMA: | 42.91 | Buy |
20-day EMA: | 39.47 | Buy |
50-day EMA: | 35.85 | Buy |
200-day EMA: | 31.56 | Buy |
Akari Therapeutics PLC Earnings Growth & AKTX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Digimarc Earnings Growth & DMRC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.31 per share, and a decrease next year of $0.00 per share.
Akari Therapeutics PLC Technical Analysis
Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Digimarc Technical Analysis
Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |